Massachusetts Financial Services Company 13D and 13G filings for Maravai LifeSciences Holdings, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2023-11-07 11:09 am Sale | 2023-11-07 | 13G | Maravai LifeSciences Holdings, Inc. MRVI | Massachusetts Financial Services Company | 6,058,247 4.600% | -6,989,713 (-53.57%) | Filing |
| 2023-02-08 4:07 pm Sale | 2023-02-08 | 13G | Maravai LifeSciences Holdings, Inc. MRVI | Massachusetts Financial Services Company | 13,047,960 9.900% | -884,724 (-6.35%) | Filing |
| 2022-09-06 4:00 pm Unchanged | 2022-09-06 | 13G | Maravai LifeSciences Holdings, Inc. MRVI | Massachusetts Financial Services Company | 13,932,684 10.600% | 0 (Unchanged) | Filing |
| 2022-09-06 2:37 pm Purchase | 2022-09-06 | 13G | Maravai LifeSciences Holdings, Inc. MRVI | Massachusetts Financial Services Company | 13,932,684 10.600% | 5,929,663 (+74.09%) | Filing |
| 2022-02-02 12:46 pm Purchase | 2022-02-02 | 13G | Maravai LifeSciences Holdings, Inc. MRVI | Massachusetts Financial Services Company | 8,003,021 6.100% | 8,003,021 (New Position) | Filing |